Sven‐Thorsten Liffers

1.1k total citations
18 papers, 795 citations indexed

About

Sven‐Thorsten Liffers is a scholar working on Molecular Biology, Oncology and Cancer Research. According to data from OpenAlex, Sven‐Thorsten Liffers has authored 18 papers receiving a total of 795 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Molecular Biology, 9 papers in Oncology and 9 papers in Cancer Research. Recurrent topics in Sven‐Thorsten Liffers's work include Pancreatic and Hepatic Oncology Research (5 papers), Cancer Genomics and Diagnostics (5 papers) and Epigenetics and DNA Methylation (4 papers). Sven‐Thorsten Liffers is often cited by papers focused on Pancreatic and Hepatic Oncology Research (5 papers), Cancer Genomics and Diagnostics (5 papers) and Epigenetics and DNA Methylation (4 papers). Sven‐Thorsten Liffers collaborates with scholars based in Germany, United States and Italy. Sven‐Thorsten Liffers's co-authors include Andrea Tannapfel, Markus Vogt, Berlinda Verdoodt, Heiko Hermeking, Johanna Münding, Lars Steinstraesser, Alireza Mirmohammadsadegh, Simone Röh, Bettina Warscheid and Silke Oeljeklaus and has published in prestigious journals such as PLoS ONE, Cancer Research and Gut.

In The Last Decade

Sven‐Thorsten Liffers

17 papers receiving 785 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Sven‐Thorsten Liffers Germany 9 579 480 207 88 56 18 795
Johannes Fredebohm Germany 12 354 0.6× 309 0.6× 210 1.0× 91 1.0× 123 2.2× 23 581
Hyung Seok Kim South Korea 17 701 1.2× 395 0.8× 145 0.7× 82 0.9× 152 2.7× 29 900
Cecil Han United States 8 543 0.9× 297 0.6× 133 0.6× 32 0.4× 47 0.8× 11 650
Yinghua He China 18 905 1.6× 634 1.3× 148 0.7× 45 0.5× 78 1.4× 26 1.1k
Marianna Scrima Italy 17 640 1.1× 302 0.6× 237 1.1× 82 0.9× 182 3.3× 30 890
Jia‐Quan Qu China 15 556 1.0× 330 0.7× 206 1.0× 39 0.4× 80 1.4× 17 756
Cui Tan China 11 370 0.6× 313 0.7× 115 0.6× 136 1.5× 42 0.8× 25 633

Countries citing papers authored by Sven‐Thorsten Liffers

Since Specialization
Citations

This map shows the geographic impact of Sven‐Thorsten Liffers's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sven‐Thorsten Liffers with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sven‐Thorsten Liffers more than expected).

Fields of papers citing papers by Sven‐Thorsten Liffers

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sven‐Thorsten Liffers. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sven‐Thorsten Liffers. The network helps show where Sven‐Thorsten Liffers may publish in the future.

Co-authorship network of co-authors of Sven‐Thorsten Liffers

This figure shows the co-authorship network connecting the top 25 collaborators of Sven‐Thorsten Liffers. A scholar is included among the top collaborators of Sven‐Thorsten Liffers based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sven‐Thorsten Liffers. Sven‐Thorsten Liffers is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
Liffers, Sven‐Thorsten, Johanna Falkenhorst, Wiebke K. Guder, et al.. (2025). Solitary fibrous tumor: a retrospective analysis of clinicopathological characteristics and palliative treatment of 67 cases. 3. 100017–100017.
2.
3.
Förster, Jan, Sven‐Thorsten Liffers, Christopher Schröder, et al.. (2024). Pancreatic cancer acquires resistance to MAPK pathway inhibition by clonal expansion and adaptive DNA hypermethylation. Clinical Epigenetics. 16(1). 13–13. 5 indexed citations
4.
Ting, Saskia, Sven‐Thorsten Liffers, Kelsey L. Pomykala, et al.. (2023). Histology-Based Prediction of Therapy Response to Neoadjuvant Chemotherapy for Esophageal and Esophagogastric Junction Adenocarcinomas Using Deep Learning. JCO Clinical Cancer Informatics. 7(7). e2300038–e2300038. 6 indexed citations
5.
Liffers, Sven‐Thorsten, Lena Häberle, Aslihan Yavas, et al.. (2022). Molecular heterogeneity and commonalities in pancreatic cancer precursors with gastric and intestinal phenotype. Gut. 72(3). 522–534. 17 indexed citations
6.
Lorenzen, Sylvie, Michael Quante, Isabel Rauscher, et al.. (2022). PET-directed combined modality therapy for gastroesophageal junction cancer: Results of the multicentre prospective MEMORI trial of the German Cancer Consortium (DKTK). European Journal of Cancer. 175. 99–106. 6 indexed citations
7.
Uhrig, Sebastian, Philipp J. Jost, Claudio Luchini, et al.. (2022). MCL1 as putative target in pancreatoblastoma. Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin. 481(2). 265–272. 5 indexed citations
8.
Neves, Rui P., Sven‐Thorsten Liffers, Jan Dominik Kuhlmann, et al.. (2021). Image-Based Identification and Genomic Analysis of Single Circulating Tumor Cells in High Grade Serous Ovarian Cancer Patients. Cancers. 13(15). 3748–3748. 5 indexed citations
9.
Liffers, Sven‐Thorsten, Johanna Falkenhorst, Hans‐Ulrich Steinau, et al.. (2021). Localized Angiosarcoma, Not One Disease: A Retrospective Single-Center Study on Prognosis Depending on the Primary Site and Etiology. Sarcoma. 2021. 1–10. 7 indexed citations
10.
Zhao, Ben, Jiangning Gu, Marija Trajkovic‐Arsic, et al.. (2020). TFEB-mediated lysosomal biogenesis and lysosomal drug sequestration confer resistance to MEK inhibition in pancreatic cancer. Cell Death Discovery. 6(1). 33 indexed citations
11.
Zhang, Xin, Feda H. Hamdan, Benedict‐Tilman Berger, et al.. (2020). Characterization of a dual BET/HDAC inhibitor for treatment of pancreatic ductal adenocarcinoma. International Journal of Cancer. 147(10). 2847–2861. 42 indexed citations
12.
Lueong, Smiths, Andreas Herbst, Sven‐Thorsten Liffers, et al.. (2020). Serial Circulating Tumor DNA Mutational Status in Patients with KRAS-Mutant Metastatic Colorectal Cancer from the Phase 3 AIO KRK0207 Trial. Clinical Chemistry. 66(12). 1510–1520. 16 indexed citations
13.
Cheung, Phyllis F., Sven‐Thorsten Liffers, Kristina Althoff, et al.. (2018). Notch-Induced Myeloid Reprogramming in Spontaneous Pancreatic Ductal Adenocarcinoma by Dual Genetic Targeting. Cancer Research. 78(17). 4997–5010. 8 indexed citations
14.
Verdoodt, Berlinda, Matthias Neid, Markus Vogt, et al.. (2013). MicroRNA-205, a novel regulator of the anti-apoptotic protein Bcl2, is downregulated in prostate cancer. International Journal of Oncology. 43(1). 307–314. 93 indexed citations
15.
Verdoodt, Berlinda, Markus Vogt, Inge Schmitz, et al.. (2012). Salinomycin Induces Autophagy in Colon and Breast Cancer Cells with Concomitant Generation of Reactive Oxygen Species. PLoS ONE. 7(9). e44132–e44132. 80 indexed citations
16.
Stricker, Ingo, Sandeep Nambiar, Sven‐Thorsten Liffers, et al.. (2012). Site- and grade-specific diversity of LINE1 methylation pattern in gastroenteropancreatic neuroendocrine tumours.. PubMed. 32(9). 3699–706. 30 indexed citations
17.
Vogt, Markus, Johanna Münding, Sven‐Thorsten Liffers, et al.. (2011). Frequent concomitant inactivation of miR-34a and miR-34b/c by CpG methylation in colorectal, pancreatic, mammary, ovarian, urothelial, and renal cell carcinomas and soft tissue sarcomas. Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin. 458(3). 313–322. 262 indexed citations
18.
Kaller, Markus, Sven‐Thorsten Liffers, Silke Oeljeklaus, et al.. (2011). Genome-wide Characterization of miR-34a Induced Changes in Protein and mRNA Expression by a Combined Pulsed SILAC and Microarray Analysis. Molecular & Cellular Proteomics. 10(8). M111.010462–M111.010462. 178 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Johannes Fredebohm Breakdown of academic impact, for papers by Hyung Seok Kim Breakdown of academic impact, for papers by Cecil Han Breakdown of academic impact, for papers by Yinghua He Breakdown of academic impact, for papers by Marianna Scrima Breakdown of academic impact, for papers by Jia‐Quan Qu Breakdown of academic impact, for papers by Cui Tan
Rankless by CCL
2026